Merck

By Dave Muoio August 17, 2018
Healthy Interactions, a population health company that offers both digital and in-person programs for chronic disease management and education, and Merck have launched a diabetes management and engagement platform designed to support in-person counseling programs. The map4health platform — which was debuted today at the American Association of Diabetes Educators Annual Conference in Baltimore —...
By Dave Muoio March 29, 2018
Physicians have touted the benefits of a good night’s sleep for centuries, if not longer, but it hasn’t been until recent years that a provider can see clear data on whether or not their patients have been hitting the sack. To investigate whether wearable sleep trackers could play a role in patient-provider conversations, researchers from Indiana University’s Regenstrief Institute have launched a...
By Jonah Comstock February 12, 2018
Correction: A previous version of this article misstated Provata's 2016 revenue. Merck subsidiary StayWell, which offers a preventative health platform for employers, health plans, and health systems, has acquired Provata Health for an undisclosed sum. Provata Health makes a digital health platform for employee wellness, which includes a chronic disease management program incorporating a...
By Jonah Comstock December 11, 2017
Cedars-Sinai Medical Center's third accelerator class held its demo day last week as the 10 companies announced a slew of pilots, deployments, and other deals. Nine out of the 10 companies has a pilot or commercial deal with Cedars-Sinai itself, but a number of companies also have deals with other hospitals, payers, or pharma companies. One, Tasso, has a $6 million grant contract with the...
By Dave Muoio October 12, 2017
Lyndhurst, New Jersey-based Vitals, maker of online healthcare transparency resources for patients, has acquired MedHelp’s online community business for an undisclosed sum. Vitals plans to merge its consumer-focused websites with MedHelp’s Patient-to-Patient Communities to form a new digital property, Vitals Consumer Services. MedHelp has been at the forefront of the news this week, as StayWell...
By Dave Muoio October 10, 2017
Update: This article has been updated to clarify MedHelp's affiliation with Merck and recent announcement of acquisition by Vitals. To expedite its push into mobile health, Yardley, Pennsylvania-based StayWell announced today that it has acquired the mobile health portion of Silicon Valley-based MedHelp, which includes several consumer-facing mobile health apps. The terms of the deal were not...
By Heather Mack June 22, 2017
As virtual private assistants like Amazon’s Alexa become smarter, more popular and more useful, why not give it them tools to recognize emotions? That seems to be the thinking behind Israel-based Beyond Verbal, which makes voice recognition software to analyze human emotion and health indicators, releasing a cloud-based API engine to integrate with virtual private assistants (VPAs). The intention...
By Tom Sullivan April 11, 2017
Amazon Web Services and Merck announced a developer competition on Monday to that plans to harness artificial intelligence for diabetics. Dubbed the Alexa Diabetes Challenge, and powered by Luminary Labs, the contest aims to incent upstarts and individual developers to create apps that harness Amazon’s Alexa voice-enabled technologies particularly for patients recently diagnosed with Type 2...
By Heather Mack July 29, 2016
During the month of July, MobiHealthNews reported on 16 digital health companies that raised venture funding. The deals total $149.3 million, which is lower on average when compared to other months this year so far but that's expected for the slower news cycle in the summer. In the first half of 2016, MobiHealthNews tracked funding for digital health companies that totaled $1.27 billion, as we...
By Heather Mack July 20, 2016
Digital medicine company Akili Interactive Labs announced an $11.9 million expansion of its recent Series B funding, adding new investors into the round and bringing the series total to $42.4 million. The Dutch subsidiary of Merck Ventures, known as M Ventures in the US and Canada, and the venture arm of Amgen joined existing investors, which include Pfizer and Shire Pharmaceuticals. This means...